Currently in preparation. Coming soon.
Thank you for your interest.
22.10
07
PL Micromed Selected as a 'National Representative of 1000 Innovative Companies'
22.18
11
World's First HALAL-Certified Absorbable Embolic Materials, 'Marine-Gel, Smart-Gel, and Smart-Gel S-MIRIP' Acquire Full-Size HALAL Certification... "Securing a Bridgehead for Entry into the Middle Eastern Market"
22.08
03
PL Micromed and Pusan National University College of Medicine GRAND Fusion Convergence Science Education Research Group (BK21) Sign a Collaborative Research MOU
22.08
01
PL Micromed, Selected as a Promising Gyeongnam Company, Participates in 'New Deal Fund Investment Briefing' for attracting funds
22.07
20
PL Micromed Registers European Patent for 'Molecular Weight-Controllable Absorbable Embolization Therapeutic Agent'
22.04
23
[Finding the Master Physician] H+ Yangji Hospital Department Head Lee Sang-hwan: "'TAME,' which eliminates inflammation by finding blood vessels with X-rays, can relieve pain for 3-4 years with a single procedure."
21.12
30
PL Micromed Confirms Wound Healing and Antibacterial Effects Through Collagen
21.12
30
PL Micromed Proves the Excellence of Low-Molecular-Weight Fish Collagen as a Material for Treating Burns and Wounds
21.12
14
PL Micromed Proves Effectiveness of Molecular Weight-Controlled Embolic Material... Published in SCI-level International Journal
21.08
27
PL Micromed Commercializes Bio-Original Technology, Boosting Efficacy and Stability by Controlling Embolization Period
21.08
26
PL Micromed Develops and Commercializes Bio-Original Technology for Controlling Embolization Period
ADD. 15-5, Yangju 3-gil, Yangsan-si, Gyeongsangnam-do, Republic of Korea
TEL. +(82)-55-381-1345
FAX. +(82)-55-381-1346
E-Mail. info@plmicromed.com
